Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
International Journal of Pharmaceutics|March 27, 2019
Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapyM Dul, T Nikolic, M Stefanidou, et al.
Acta Biomaterialia|June 15, 2018
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral qualityL Xi, P De Falco, E Barbieri, et al.
Archives of Otolaryngology--Head & Neck Surgery|August 1, 1996
A novel organ preservation protocol for advanced carcinoma of the larynx and pharynxK T Robbins, J Fontanesi, F S Wong, et al.
Bone|November 15, 2019
Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructureL Xi, P De Falco, E Barbieri, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experienceK T Robbins, P Kumar, W F Regine, et al.
Immunity|January 26, 2021
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinomaJuan Dubrot, Sarah Kate Lane-Reticker, Emily A Kessler, et al.
Immunotherapy Advances|August 3, 2022
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetesD Tatovic, M A McAteer, J Barry, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 17